Evidence map›Paper›PMID 31496696›Full record

ArticleInternational journal of nanomedicine2019

Anticancer and antibacterial effects of a clove bud essential oil-based nanoscale emulsion system.

M Joyce Nirmala, Latha Durai, Vineet Gopakumar, R Nagarajan

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Anticancer Potential ofPlants (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Frontiers in microbiology · 2025
    Review
  7. Article
  8. In Vitro and In Silico Evaluation ofPlants (Basel, Switzerland) · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Multi-Targeting Neuroprotective Effects ofInternational journal of molecular sciences · 2023
    Article
  13. Review
  14. Review
  15. Antibiotics (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Essential Oils and Neuropathic Pain.Plants (Basel, Switzerland) · 2022
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M Joyce NirmalaDepartment of Chemical Engineering, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.
Latha DuraiDepartment of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.
Vineet GopakumarDepartment of Chemical Engineering, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.
R NagarajanDepartment of Chemical Engineering, Indian Institute of Technology Madras, Chennai 600036, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe essential oil derived from clove buds (

methodsNanoscale-based emulsions were prepared by employing a spontaneous emulsification technique through self-assembly using varying concentrations of Tween 20 and Tween 80 surfactants. Their physicochemical properties and stability were studied in order to choose an optimum formulation which was clear and stable. The cytotoxicity of the stable oil-based emulsion system was evaluated using MTT assay, colony formation assay, and Annexin V-FITC assay against the thyroid cancer cell line (HTh-7).

resultsAll three methods verified apoptosis and reduction in cancer cell proliferation, making the formulation a promising candidate as an alternative cancer drug. The oil-based emulsion system was also tested for its antibacterial properties against

conclusionMany current treatments for cancers are aggressive yet ineffective. This study positions the clove bud-based nanoscale emulsion as a suitable candidate for further in vivo studies and trials as a cancer drug.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsCell Line, TumorCell Membrane PermeabilityCell SurvivalDrug CompoundingEmulsionsHumansHydrogen-Ion ConcentrationMicrobial Sensitivity TestsOils, VolatileStaphylococcus aureusSurface-Active AgentsSyzygiumViscosityAnti-Bacterial AgentsAntineoplastic AgentsEmulsionsOils, VolatileSurface-Active Agentsantibacterial activityapoptosisclove bud oilnanoscale emulsion systemthyroid cancer

Identifiers

PMID31496696
PMCPMC6697666

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.